Synergy CHC (NASDAQ:SNYR – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($1.54) EPS for the quarter, FiscalAI reports. Synergy CHC had a net margin of 7.77% and a negative return on equity of 19.51%. The firm had revenue of $6.07 million during the quarter.
Here are the key takeaways from Synergy CHC’s conference call:
- Beverage momentum in early 2026 — management reports >$600,000 of gross revenue year-to-date in Q1 2026 (surpassing all of 2025) and a ~ $2.5M run-rate, with major new distribution placements and millions of cans in stock ready to ship.
- Large one-time charges drove the quarterly and annual losses — the company recorded an allowance for bad debt (~$6.66M), reversal/termination of international license revenue (~$2.9M), obsolete inventory write-off (~$1.04M), and prepaid media write-off (~$0.9M), which materially reduced Q4 and full-year results and adjusted EBITDA.
- Retail execution and growth initiatives — shipped new supplement SKUs to all ~1,600 Kroger locations and began shipments to Costco de México after forming a Mexican subsidiary, plus plans to restart TV advertising (management expects ~15% same-store lift).
- Balance sheet and working capital mixed picture — cash increased to $2.6M and working capital moved to a $1.78M surplus, but inventory rose to $3.7M and total liabilities remained roughly flat at ~$33M, leaving liquidity and execution risks to monitor.
Synergy CHC Stock Down 21.6%
Shares of NASDAQ:SNYR opened at $0.80 on Friday. The firm has a market cap of $9 million, a P/E ratio of -0.75 and a beta of 2.92. Synergy CHC has a 12-month low of $0.71 and a 12-month high of $4.08. The business has a fifty day simple moving average of $1.47 and a 200 day simple moving average of $1.90.
Hedge Funds Weigh In On Synergy CHC
Wall Street Analysts Forecast Growth
Several research firms have commented on SNYR. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synergy CHC in a research report on Friday, March 27th. Ascendiant Capital Markets began coverage on Synergy CHC in a research note on Monday, February 2nd. They issued a “buy” rating and a $5.00 price objective for the company. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Synergy CHC presently has a consensus rating of “Moderate Buy” and an average price target of $6.00.
Read Our Latest Stock Report on SNYR
About Synergy CHC
Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.
See Also
Receive News & Ratings for Synergy CHC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synergy CHC and related companies with MarketBeat.com's FREE daily email newsletter.
